NCT03789253
Identify Genes/Pathways Responsible for Progression From Low Risk to Higher Risk Prostate Cancer
StatusRecruiting
PhaseNot specified
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 4 versions: 3 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗
- Notable Primary completion moved earlier from Jul 31, 2030 to Jul 31, 2028
- Eligibility criteria expanded, about 5 words
- Notable Trial status: Not Yet Recruiting to Recruiting
- Primary and study completion dates: Dec 31, 2021 to Jul 31, 2030
- Primary endpoint revised
- Study sites: 0 to 1
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Gene expression
Timeframe: 3 years
Arms and interventions
AS cohort with progression
AS cohort with tumor progression
AS cohort without progression
AS cohort without tumor progression
Sites
1 site in 1 country
- National Taiwan UniversityTaipei, Taiwan